Orion Oyj (ORINF)
USD 48.65
(0.0%)
USD 48.65
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 362.2 Million EUR | 14.77% |
| 2022 | 315.6 Million USD | 4.7% |
| 2021 | 301.43 Million EUR | -4.55% |
| 2020 | 315.79 Million EUR | 22.16% |
| 2019 | 258.51 Million EUR | 16.39% |
| 2018 | 222.1 Million EUR | -1.46% |
| 2017 | 225.4 Million EUR | -0.92% |
| 2016 | 227.5 Million EUR | 1.81% |
| 2015 | 223.45 Million EUR | 25.04% |
| 2014 | 178.7 Million EUR | -8.59% |
| 2013 | 195.5 Million EUR | 9.1% |
| 2012 | 179.2 Million EUR | 18.36% |
| 2011 | 151.4 Million EUR | 15.48% |
| 2010 | 131.1 Million EUR | 6.85% |
| 2009 | 122.7 Million EUR | -6.83% |
| 2008 | 131.7 Million EUR | 8.75% |
| 2007 | 121.1 Million EUR | 12.97% |
| 2006 | 107.2 Million EUR | -61.97% |
| 2005 | 281.9 Million EUR | -5.72% |
| 2004 | 299 Million EUR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 404.4 Million EUR | 5.12% |
| 2024 Q2 | 384.7 Million EUR | 3.83% |
| 2024 Q1 | 399.76 Million EUR | 2.29% |
| 2023 Q3 | 364.37 Million USD | -4.8% |
| 2023 Q2 | 382.74 Million USD | 7.63% |
| 2023 Q1 | 355.59 Million USD | 5.28% |
| 2023 Q4 | 399.77 Million EUR | 9.71% |
| 2023 FY | 362.2 Million EUR | 14.77% |
| 2022 Q4 | 337.77 Million USD | 11.5% |
| 2022 FY | 315.6 Million USD | 4.7% |
| 2022 Q1 | 274.8 Million EUR | 3.62% |
| 2022 Q2 | 332 Million EUR | 20.82% |
| 2022 Q3 | 302.92 Million EUR | -8.76% |
| 2021 Q2 | 323.51 Million EUR | 7.78% |
| 2021 Q4 | 265.2 Million EUR | -2.71% |
| 2021 Q3 | 272.6 Million EUR | -15.74% |
| 2021 Q1 | 300.17 Million EUR | 16.3% |
| 2021 FY | 301.43 Million EUR | -4.55% |
| 2020 Q1 | 232.2 Million EUR | 0.83% |
| 2020 FY | 315.79 Million EUR | 22.16% |
| 2020 Q2 | 251.1 Million EUR | 8.14% |
| 2020 Q3 | 254.6 Million EUR | 1.39% |
| 2020 Q4 | 258.1 Million EUR | 1.37% |
| 2019 FY | 258.51 Million EUR | 16.39% |
| 2019 Q4 | 230.3 Million EUR | 0.44% |
| 2019 Q2 | 226.7 Million EUR | 2.86% |
| 2019 Q3 | 229.3 Million EUR | 1.15% |
| 2019 Q1 | 220.4 Million EUR | -0.77% |
| 2018 Q1 | 216 Million EUR | -4.17% |
| 2018 FY | 222.1 Million EUR | -1.46% |
| 2018 Q4 | 222.1 Million EUR | 0.95% |
| 2018 Q3 | 220 Million EUR | -2.57% |
| 2018 Q2 | 225.8 Million EUR | 4.54% |
| 2017 Q1 | 236.8 Million EUR | 4.09% |
| 2017 FY | 225.4 Million EUR | -0.92% |
| 2017 Q4 | 225.4 Million EUR | 3.06% |
| 2017 Q3 | 218.7 Million EUR | -8.26% |
| 2017 Q2 | 238.4 Million EUR | 0.68% |
| 2016 Q1 | 207.7 Million EUR | 0.97% |
| 2016 FY | 227.5 Million EUR | 1.81% |
| 2016 Q4 | 227.5 Million EUR | 4.17% |
| 2016 Q3 | 218.4 Million EUR | 2.25% |
| 2016 Q2 | 213.6 Million EUR | 2.84% |
| 2015 Q3 | 189.5 Million EUR | -4.96% |
| 2015 FY | 223.45 Million EUR | 25.04% |
| 2015 Q4 | 205.7 Million EUR | 8.55% |
| 2015 Q2 | 199.4 Million EUR | 6.97% |
| 2015 Q1 | 186.4 Million EUR | 4.31% |
| 2014 Q2 | 196.2 Million EUR | -0.91% |
| 2014 Q3 | 185.2 Million EUR | -5.61% |
| 2014 Q4 | 178.7 Million EUR | -3.51% |
| 2014 FY | 178.7 Million EUR | -8.59% |
| 2014 Q1 | 198 Million EUR | 1.28% |
| 2013 Q2 | 196.2 Million EUR | 3.7% |
| 2013 Q1 | 189.2 Million EUR | 5.58% |
| 2013 FY | 195.5 Million EUR | 9.1% |
| 2013 Q4 | 195.5 Million EUR | -2.05% |
| 2013 Q3 | 199.6 Million EUR | 1.73% |
| 2012 Q3 | 170.2 Million EUR | 1.13% |
| 2012 Q2 | 168.3 Million EUR | 7.27% |
| 2012 Q1 | 156.9 Million EUR | 3.63% |
| 2012 FY | 179.2 Million EUR | 18.36% |
| 2012 Q4 | 179.2 Million EUR | 5.29% |
| 2011 Q2 | 143 Million EUR | 4.46% |
| 2011 Q3 | 147.7 Million EUR | 3.29% |
| 2011 Q4 | 151.4 Million EUR | 2.51% |
| 2011 Q1 | 136.9 Million EUR | 4.42% |
| 2011 FY | 151.4 Million EUR | 15.48% |
| 2010 FY | 131.1 Million EUR | 6.85% |
| 2010 Q3 | 127.5 Million EUR | -1.62% |
| 2010 Q4 | 131.1 Million EUR | 2.82% |
| 2010 Q1 | 123.8 Million EUR | 0.9% |
| 2010 Q2 | 129.6 Million EUR | 4.68% |
| 2009 FY | 122.7 Million EUR | -6.83% |
| 2009 Q4 | 122.7 Million EUR | 0.0% |
| 2008 FY | 131.7 Million EUR | 8.75% |
| 2007 FY | 121.1 Million EUR | 12.97% |
| 2006 Q4 | 107.2 Million EUR | 0.0% |
| 2006 FY | 107.2 Million EUR | -61.97% |
| 2005 FY | 281.9 Million EUR | -5.72% |
| 2004 FY | 299 Million EUR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| AstraZeneca PLC | 5.41 Billion USD | 93.313% |
| Bristol-Myers Squibb Company PFD CONV 2 | 2.66 Billion USD | 86.394% |
| CSPC Pharmaceutical Group Limited | 442.43 Million USD | 18.134% |
| Clarus Therapeutics Holdings, Inc. | 14.21 Million USD | -2448.192% |
| Novartis AG | 5.91 Billion USD | 93.875% |
| PT Kalbe Farma Tbk. | 451.27 Million USD | 19.739% |